Table 1. Baselines demographics of enrolled patients.
| All patients (n=143) | SR (n=90) | TACE (n=53) | P | |
|---|---|---|---|---|
| Age (years) | 65.0, 54.0−76.0 | 62.0, 52.0−72.0 | 73.0, 61.5−79.0 | 0.001 |
| Gender (M/F) (%) | 117/26 (81.8/18.2) | 75/15 (83.3/16.7) | 42/11 (79.2/20.8) | 0.540 |
| BMI (kg/m2) | 23.6, 21.5−25.9 | 24.0, 21.9−26.2 | 23.0, 20.9−25.4 | 0.283 |
| AFP (ng/mL) | 92.0, 5.2−6,595.3 | 87.7, 4.3−6,944.2 | 123.7, 9.0−6,309.8 | 0.583 |
| Tumor size (cm) | 12.4, 11.0−14.4 | 12.4, 11.0−14.3 | 12.4, 10.8−15.0 | 0.665 |
| HBsAg (+/−) (%) | 82/54 (60.3/39.7) | 57/30 (65.5/34.5) | 25/24 (51/49) | 0.097 |
| Anti-HCV (+/−) (%) | 15/110 (12/88) | 6/72 (7.7/92.3) | 9/38 (19.1/80.9) | 0.056 |
| MELD | 8.3, 7.2−9.7 | 8.0, 7.1−9.7 | 8.7, 7.3−10.1 | 0.746 |
| ALBI | −2.46, −2.79−2.11 | −2.49, −2.87−2.11 | −2.31, −2.67−1.96 | 0.053 |
| ALBI (1/2/3) (%) | 53/82/7 (37.3/57.7/4.9) | 36/51/3 (40/56.7/3.3) | 17/31/4 (32.7/59.6/7.7) | 0.386 |
| Child-Pugh class (A/B) (%) | 122/5 (96.1/3.9) | 78/4 (95.1/4.9) | 44/1 (97.8/2.2) | 0.655 |
| Albumin(mg/dL) | 3.7, 3.4−4.1 | 3.7, 3.4−4.2 | 3.6, 3.3−4.0 | 0.215 |
| Bilirubin (U/L) | 0.80, 0.58−1.15 | 0.74, 0.57−1.06 | 0.92, 0.63−1.51 | 0.080 |
| Platelet (/mm3) | 217,000, 160,000−284,000 | 226,000, 167,000−297,000 | 196,000, 148,000−256,000 | 0.129 |
| PT INR | 1.07, 1.02−1.14 | 1.07, 1.01−1.14 | 1.07, 1.02−1.18 | 0.340 |
| Hgb (mg/dL) | 12.5, 10.9−14.1 | 12.8, 11.4−14.5 | 11.9, 10.0−13.6 | 0.167 |
| BUN (mg/dL) | 16, 12−19 | 15, 11−19 | 17, 12−20 | 0.062 |
| Creatinine (mg/dL) | 0.91, 0.75−1.12 | 0.90, 0.74−1.10 | 0.95, 0.76−1.17 | 0.594 |
| ALT (U/L) | 43, 28−71 | 39, 26−72 | 46, 32−71 | 0.795 |
| GGT (U/L) | 87, 54−151 | 82, 50−124 | 114, 58−214 | 0.457 |
| ALKP (U/L) | 112, 82−161 | 103, 79−133 | 138, 96−191 | 0.054 |
Continuous variables are expressed as the median with 25th and 75th percentiles. SR, surgical resection; TACE, transarterial chemoembolization; BMI, body mass index; AFP, α-fetoprotein; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; MELD, model for end-stage liver disease; ALBI, albumin-bilirubin; PT INR, prothrombin time/international normalized ratio; HgB, hemoglobulin; ALT, alanine aminotransferase; GGT, γ-glutamyl transferase; ALKP, alkaline phosphatase.